ArticleJournal of cellular biochemistry2022

Integrative multiomics and in silico analysis revealed the role of ARHGEF1 and its screened antagonist in mild and severe COVID-19 patients.

Prakash Jha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.